Pharmacy Patient Satisfaction Highlights SPT Week in Review

Top articles of the week from Specialty Pharmacy Times.

3. Pembrolizumab Approved for Any Solid Tumor Containing a Common Biomarker

Indication for the treatment of adults and pediatric patients with solid tumors containing MSI-H or dMMR.

2. Sarilumab Receives FDA Approval for Rheumatoid Arthritis

Sarilumab plus DMARDs demonstrated statistically significant improvements in patients with moderate to severe RA.

1. Impact of Patient Satisfaction on Specialty Pharmacy

Satisfaction surveys improve understanding of the patient journey and define specialty pharmacy excellence.